ASX RELEASE 15 September 2026 Dr Daniel Furtner appointed Chief Medical Officer, Dr Donna Skerrett continues as Senior Scientific Advisor Paradigm Biopharmaceuticals Ltd (ASX:PAR) (“Paradigm” or “the...
Dr Daniel Furtner appointed Chief Medical Officer
Filed with ASX · · 2 pages · English
Release
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Application for quotation of securities - PAR
- Notice under Section 708A
- Notification regarding unquoted securities - PAR
- Drawdown of Tranche 4 under the Convertible Note Facility
- Melbourne Investor Lunch
Later from Paradigm Biopharmaceuticals
- Trading Halt
- Suspension from Quotation
- Phase 3 Interim Result Below Continuation Threshold
- Notification of cessation of securities - PAR
- Agreement to Return US$2M to Obsidian
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals